Fidelity International’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,252,000
Closed -$133M 996
2024
Q2
$133M Buy
3,252,000
+3,000
+0.1% +$123K 0.13% 186
2024
Q1
$137M Buy
3,249,000
+483,000
+17% +$20.4M 0.14% 178
2023
Q4
$117M Buy
+2,766,000
New +$117M 0.12% 208